Diego Hernández García-Gallardo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diego Hernández García-Gallardo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ana Isabel Pérez Zapata
Hospital Royo Villanova, Zaragoza, Spain
1 shared publication - Cristina Alegre Torrado
12 de Octubre Hospital, Madrid, Spain
1 shared publication - Eduardo Ferrero Herrero
Hospital Universitario 12 de Octubre, Madrid, Spain
1 shared publication - Elias Rodriguez-Cuellar
Sección de Cirugía Esofagogástrica y Bariátrica, Hospital Universitario 12 de Octubre, Madrid, Spain
1 shared publication - Felipe de la Cruz Vigo
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
1 shared publication - Javier Martínez Caballero
12 de Octubre Hospital, Madrid, Spain
1 shared publication
Latest Publications
- 31 December 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (3) , 965-968
Ligamentum Teres Cardiopexy Might Not Prevent Gastro-esophageal Reflux After Laparoscopic Sleeve Gastrectomy: Case Series
Roux-en-Y gastric bypass (RYGB) is considered the gold standard procedure in patients with obesity and gastroesophageal reflux (GERD), but in patients with preoperative hiatal hernia (HH) or GERD, who are unfit for RYGB, there are no clear guidelines. Ligamentum teres cardiopexy (LTC) has been proposed as an effective alternative. The purpose of this study was to analyze medium-term results of LTC procedure associated with laparoscopic sleeve gastrectomy (LSG) in patients with GERD or HH, according to the absence of pathologic acid reflux in esophageal 24 h pH monitoring test, symptom release, or PPI reduction. Five patients underwent LSG-LTC between March 2018 and October 2019. In one patient, the effectiveness of LTC as an anti-reflux procedure could not be assessed because of conversion to RYGB was required. After a follow-up period of 30 [24–42] months and excessive BMI loss of 62.74 ± 18.18%, GERD recurrence was observed in 75% of patients. The study was discontinued due to unsatisfactory preliminary results with LTC. Our results suggest that LTC might not prevent GERD after LSG in patients with preoperative GERD or HH. Graphical Abstract
- 31 December 2022
- Published by Springer Nature in Obesity Surgery
- Vol. 33 (3) , 965-968
Ligamentum Teres Cardiopexy Might Not Prevent Gastro-esophageal Reflux After Laparoscopic Sleeve Gastrectomy: Case Series
Roux-en-Y gastric bypass (RYGB) is considered the gold standard procedure in patients with obesity and gastroesophageal reflux (GERD), but in patients with preoperative hiatal hernia (HH) or GERD, who are unfit for RYGB, there are no clear guidelines. Ligamentum teres cardiopexy (LTC) has been proposed as an effective alternative. The purpose of this study was to analyze medium-term results of LTC procedure associated with laparoscopic sleeve gastrectomy (LSG) in patients with GERD or HH, according to the absence of pathologic acid reflux in esophageal 24 h pH monitoring test, symptom release, or PPI reduction. Five patients underwent LSG-LTC between March 2018 and October 2019. In one patient, the effectiveness of LTC as an anti-reflux procedure could not be assessed because of conversion to RYGB was required. After a follow-up period of 30 [24–42] months and excessive BMI loss of 62.74 ± 18.18%, GERD recurrence was observed in 75% of patients. The study was discontinued due to unsatisfactory preliminary results with LTC. Our results suggest that LTC might not prevent GERD after LSG in patients with preoperative GERD or HH. Graphical Abstract